Ampelopsin

Ampelopsin

SCHEMBL723736

O=C1c2c(O)cc(O)cc2O[C@H](c2cc(O)c(O)c(O)c2)[C@H]1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYNJ2 O15056 3/20 1.00
SOST Q9BQB4 2/20 1.00
APP P05067 1/20 1.00
RECQL P46063 4/20 0.75
KDM4E B2RXH2 2/20 0.75
MAPT P10636 2/20 0.75
ALOX15 P16050 2/20 0.75
HSD17B10 Q99714 2/20 0.75
MEN1 O00255 1/20 0.75
KMT2A Q03164 1/20 0.75
POLB P06746 1/20 0.75
GAA P10253 1/20 0.75
CYP1A2 P05177 1/20 0.75
CYP3A4 P08684 1/20 0.75
ALOX12 P18054 1/20 0.75
NFKB1 P19838 1/20 0.75
MAPK1 P28482 1/20 0.75
HIF1A Q16665 1/20 0.75
XDH P47989 2/20 0.74
TDP1 Q9NUW8 2/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ampelopsin SCHEMBL134531 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL22750858 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL29462401 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL29138729 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL29362330 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL134532 1.00 SYNJ2 (1.00) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL544092 0.99 SYNJ2 (0.97) SYNJ2SOSTAPPRECQLKDM4E
Ampelopsin SCHEMBL28158121 0.93 SOST (0.87) SYNJ2SOSTAPPRECQLKDM4E
SCHEMBL15545301 0.91 SOST (0.83) SYNJ2SOSTAPPRECQLKDM4E
SCHEMBL21587452 0.91 SYNJ2 (0.82) SYNJ2SOSTAPPRECQLKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 303 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120202190-A Isoquinoline derivatives as protein degrading agents, E7 degrading agents, antiviral agents, tumor therapeutic agents and immunosuppressants RDP制药股份公司 2025-06-24 CN claimed
EP-4548977-A2 NOVEL ISOQUINOLINES AS PROTEIN DEGRADERS, E7 DEGRADERS, ANTIVIRALS, TUMOR THERAPEUTICS AND IMMUNE SUPPRESSIVES RDP Pharma AG (CH) 2025-05-07 EP claimed
US-20240315965-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2024-09-26 US claimed
EP-4322949-A1 ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS RDP Pharma AG (CH) 2024-02-21 EP claimed
WO-2022219157-A1 ISOQUINOLINE DERIVATIVES FOR USE AS ANTIVIRAL AND ANTITUMOUR AGENTS VALDOSPAN GMBH (AT) 2022-10-20 WO claimed
WO-2022182527-A1 COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS Natural Extraction Systems, LLC (US) 2022-09-01 WO claimed
WO-2022122968-A1 COMPOUNDS FOR USE IN THE TREATMENT OF COVID-19 DOMPE' FARMACEUTICI SPA (IT) 2022-06-16 WO claimed
WO-2021042001-A1 COMPOSITIONS AND METHODS RELATED TO DISSOLVED OXIDES Natural Extraction Systems, LLC (US) 2021-03-04 WO claimed
CN-105949169-A Ampeloptin medicine composition and application thereof to biological medicine 淄博夸克医药技术有限公司 2016-09-21 CN claimed
US-9139551-B2 Preparation of a new class of water-soluble ammonium 2,3-dihydroxy-5-((2R,3R)-3,5,7-trihydroxy-4-oxochroman-2-yl) phenolates and their biological activity of alcohol elimination JIANG XIANXING (CN) 2015-09-22 US claimed
US-20150203465-A1 Preparation Of A New Class Of Water-Soluble Ammonium 2,3-Dihydroxy-5-((2R,3R)-3,5,7-Trihydroxy-4-Oxochroman-2-Yl) Phenolates And Their Biological Activity Of Alcohol Elimination JIANG XIANXING (CN) 2015-07-23 US claimed
CN-104721181-A Application of dihydromyricetin for preparation of preparation for promoting sleep and improving sleep quality LUO GUANDI 2015-06-24 CN claimed
CN-102772398-A Application of dihydromyricetin in preparation of drug preventing and treating influenza GUIZHOU INST BIOLOGY 2012-11-14 CN claimed
CN-101336978-A Extraction method of total flavone of Hovenia dulcisThunb UNIV NORTHWEST SCI TECH AGRI (CN) 2009-01-07 CN claimed
CN-101336987-A Preparation method of total flavone of Hovenia dulcisThunb UNIV NORTHWEST SCI TECH AGRI (CN) 2009-01-07 CN claimed
CN-122081128-A Lactobacillus rhamnosus and application thereof 2026-05-26 CN disclosed
CN-122005956-A Low-viscosity easy-absorption human body lubricant and preparation method thereof 优护优家健康科技(江苏)有限公司 2026-05-12 CN disclosed
US-4933399-A COATING INSIDE OF VESSEL WITH A CATIONIC DYE, DRYING, COATING WITH AN ANIONIC OR AMPHOTERIC POLYMER OR A HYDROXYL-CONTAINING COMPOUND IN A SOLVENT SHIN-ETSU CHEMICAL CO., LTD. (JP) 1990-06-12 US disclosed
CN-1035118-A A kind of method that forms polymer-scale that stops SHINETSU CHEMICAL CO (JP) 1989-08-30 CN disclosed
EP-0320227-A2 Method of preventing polymer-scale formation Shin-Etsu Chemical Co., Ltd. (JP) 1989-06-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150203465-A1 Preparation Of A New Class Of Water-Soluble Ammonium 2,3-Dihydroxy-5-((2R,3R)-3,5,7-Trihydroxy-4-Oxochroman-2-Yl) Phenolates And Their Biological Activity Of Alcohol Elimination DBH, ADH1A, ADH1C SYNJ2 3717/4885SOST 4046/4885APP 4016/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.